Brief: NovaBay Pharmaceuticals Announces Closing Of $3.87 Mln Underwritten Public Offering
29/07/2024 21:26
July 29 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS ANNOUNCES CLOSING OF $3.87 MILLION
UNDERWRITTEN PUBLIC OFFERING, INCLUDING PARTIAL EXERCISE OF
OVERALLOTMENT OPTION
Source text for Eikon: ID:nBwc6865Fa
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing